Heart failure remains one of the most common reasons for emergency hospital admission, and readmission rates are high when post-discharge follow-up is poor or in frequent. There is good evidence that multidisciplinary programmes are effective at reducing the risk of readmission to hospital for patients recently discharged after treatment of acute decompensation, particularly where these programmes include frequent contact with the patient at home, either physically or by telephone 1 or by remotely monitoring physiological data. 2 Much less attention has been directed to avoiding hospital admission altogether for those experiencing the crisis of acute decompensation by providing greatly increased clinical support at home-the "hospital at home" concept.
This model has been examined in the past decade in a number of small randomised trials, chiefl y in older people and in conditions such as chronic obstructive airway disease or stroke. Meta-analysis suggests that such programmes can be as effective as hospital admission for selected patients, and cost the same or less than hospital admission, provided the hospital-at-home team is working at full capacity. 3 Tibaldi and colleagues report the results of a small (N = 101) randomised trial in older patients in Turin, Italy, with known chronic heart failure and a previous admission for decompensation. On admission to the emergency room, patients were randomised to hospital admission under the care of the geriatric team (not cardiologists) or the hospital-at-home team. The latter was run by a team of physicians and nurses, who visited the patients an average of 11 and 14 times, respectively, over an average period of 21 days. This compared with an average of 12 days' admission for those hospitalised. Intensive monitoring and therapy could be provided at home, including where necessary central venous access, arterial blood pressure monitoring and intravenous medication.
Although the study was underpowered to be a formal test of non-inferiority of the hospital-at-home approach, the mortality and subsequent hospitalisation experience of the two groups were very similar, although time to the fi rst readmission was slightly delayed in the at-home group. Limited economic analysis suggested that the overall cost per patient was €300 lower in the athome group, although this did not take into account the costs of informal care provided by family members. The at-home approach appeared acceptable to patients and carers, although only 19% of all heart failure admissions screened during the study period were enrolled in the study owing to geographical constraints, lack of family support, or dementia and other serious co-morbidities.
Before this model of care is adopted as part of a portfolio of approaches to reducing (potentially unnecessary) hospital admission for acute decompensation of heart failure, it is important to remember that this study is small and compared hospital at home with geriatric rather than specialist heart failure hospital care. Larger studies are required to confi rm the effi cacy and safety of this approach for heart failure and should compare hospital at home with best rather than usual hospital practice. This is particularly important as reorganising place of care within a hospital is likely to be far easier than developing the complex multiprofessional infrastructure for a community-based "outreach" team. 4 The funding mechanism for the hospital-at-home approach is likely to vary from one healthcare setting to another. It may be challenging where a hospital team reaches out and extends its responsibility to the home setting without the ability to claim for the costs of a hospitalisation episode. Such funding issues are also relevant to telemonitoring, which is becoming more commonplace and may be able to detect deterioration earlier and trigger changes to therapy that might avoid the "crisis" that leads to an emergency room visit in the fi rst place. 2 Undoubtedly, modern evidence-based heart failure care requires an effective multidisciplinary service that allows the patient (and family) to access appropriate expertise at the appropriate time. For some patients hospitalisation may be required, and may be life-saving, but for many such hospitalisation is potentially avoidable by good chronic disease management, effective communication and monitoring of the condition by the patient and the healthcare team. The hospital-at-home approach looks promising, and if the results of Tibaldi's work are confi rmed by larger randomised trials, it may become part of a range of services that can be made available for patients in the future.
